Samuel D. Riccitelli's most recent trade in OrthoPediatrics corp was a trade of 11,436 Common Stock done . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OrthoPediatrics corp | Samuel D. Riccitelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 11,436 | 31,859 (0%) | 0% | 0 | Common Stock | |
| OrthoPediatrics corp | Samuel D. Riccitelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 8,401 | 20,423 (0%) | 0% | 0 | Common Stock | |
| OrthoPediatrics corp | Samuel D. Riccitelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 2,766 | 12,022 (0%) | 0% | 0 | Common Stock | |
| OrthoPediatrics corp | Samuel D. Riccitelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,965 | 9,256 (0%) | 0% | 0 | Common Stock | |
| OrthoPediatrics corp | Samuel D. Riccitelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 1,691 | 7,291 (0%) | 0% | 0 | Common Stock | |
| Biocept Inc | Samuel D. Riccitelli | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 250,000 | 250,000 | - | - | Stock Option (right to buy) |